Preliminary List of Invited Presentations

​​​​​​​​

Angiogenesis, Cell Therapy​

The role of progenitor cells in cardiac repair - from rodents to humans

Noel M. Caplice, Biosciences Institute, University College Cork, Cork, Ireland

Placenta-derived cell therapy

Sigrid Nikol, ASKLEPIOS Klinik St. Georg, Hamburg, Germany

Stem cell treatment of critical limb ischemia – the SCELTA trial

Sergio Castellani, Azienda Ospedaliera Careggi, Florence, Italy​

The immune system, myocardial regeneration and repair

Jonathan Leor, Neufeld Cardiac Research Institute, Sheba Medical Center and Tel Aviv University, Tel Hashomer, Israel​

Seeing stem cell biology in the light of physical energies: Mutant vibrations for regenerative medicine

Carlo Ventura, University of Bologna, Bologna, Italy

Gene therapy in the prevention of intimal hyperplasia and restenosis following coronary intervention

Devendra K. Agrawal, Creighton University School of Medicine, Omaha NE, USA​



Basic Research, Molecular Biology

Can we improve myocardial protection during ischemic injury?

Roberto Ferrari, Universita Di Ferrara - Divisione Di Cardiologia, Italy

Corneal lipid deposition in disorders of lipoprotein metabolism

Howard S. Kruth, National Heart lung and Blood Institutes, Bethesda MD, USA

Function of ABCA1 and ABCG1 in extracellular cholesterol deposition by Macrophages

Xueting Jin, National Heart Lung and Biood Institutes, Bethesda MD, USA


Focus Session: Mitochondrial Dynamics and Heart Disease

Keeping mitochondria in shape: a matter of life and death

Luca Scorrano, Venetian Institute of Molecular Medicine, Venice, Italy

 

Mitochondrial Ca2+ homeostasis and ROS formation between heart injury and protection

Fabio Di Lisa, Università di Padova, Padua, Italy

 

Cardioprotection: a tale of 2 mechanisms

Joseph Hill, UT Southwestern Medical Center, Dallas TX, USA

 

The role of mitochondrial bioenergetics in cell survival​

Maha Abdellatif, New Jersey Medical School, Rutgers NJ, USA

 

From energy conservation to energy dissipation, a dual life for the mitochondrial ATP synthase

Paolo Bernardi, Università di Padova, Padua, Italy​


Molecular regulation of autophagy and cell death signaling pathways in heart failure

Lorrie A. Kirshenbaum, St. Boniface Hospital Research Center, University of Manitoba, Winnipeg, Manitoba, Canada


Atherosclerosis, Vascular Biology

Atheromatous plaque regression: A feasible objective?

Juan Carlos Kaski, St George's Hospital Medical School, London, UK

Inflammation as a therapeutic target in cardiovascular disease

Rebecca Ritchie, Baker Institute, Melbourne, Australia​


ACS: Cells, Vesicles, Molecules

Endothelium in acute coronary syndrome
Alexander Shpektor, Department of Cardiology, Moscow State University of Medicine and Dentistry named after A.I. Evdokimov, Moscow, Russia

Molecular mechanisms of myocardial protection
Qin Chen, Department of Pharmacology, University of Arizona, Tucson, Arizona, USA

Herpesviruses and ACS
E. Vasilieva, Department of Cardiology, Moscow State University of Medicine and Dentistry named after A.I. Evdokimov, Moscow, Russia

Extracellular vesicles and atherosclerosis
L. Margolis, Program in Physical Biology, Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institutes of Health, Bethesda, USA

Atheromatous plaque regression: A feasible objective? 
Juan Carlos Kaski, St George's Hospital Medical School, London, UK​​



Prevention, Lipid Management, Diabetes

Role of statins for cardiac protection: basic mechanisms

Qin M. Chen, College of Pharmacy, University of Arizona, Tucson AZ, USA
​​

Statin intolerance - definition, mechanism, management (2015)

Maciej Banach, Medical University of Lodz, Lodz, Poland

Potential role of Anti-PCSK9 monoclonal antibodies in the management of hypercholesterolemia

Norman E. Lepor, Cedars-Sinai Medical Center, Los Angeles CA, USA

Developments in familial hypercholesterolemia diagnosis and management

Andrzej Rynkiewicz, Medical University of Gdansk, Gdansk, Poland

Dyslipemia in diabetics treated with statins: results of the DYSIS study in Spain

Jesus M. Núñez-Cortés, Facultad de Medicina de la Universidad Complutense, Spain

The role of novel anti-diabetic agents on cardiovascular risk: focus on incretin-based therapies and SGLT-2 inhibitors

Manfredi Rizzo, University of Palermo, Italy

Pharmacological approaches to the prevention of diabetes-induced vascular dysfunction

Owen L. Woodman, Royal Melbourne Institute of Technology (RMIT) University, Bundoora, Victoria, Australia​

Diagnostic Methods

Cardiac CT for risk assessment

Stephan Achenbach, Friedrich-Alexander-Universitat Erlangen-Nurnberg, Germany

Outcome prediction in asymptomatic diabetics with special reference to coronary CT angiography

David A. Halon, Lady Davis Carmel Medical Center and the Ruth and Bruce Rappaport School of Medicine, Haifa, Israel

Clinical value of CAC measurement: What have we learnt?​ 

Joseph Shemesh, Sheba Medical Center, Israel

Myocardial fibrosis imaging with MRI: contrast or non-contrast?

Jie Zheng, Mallinckrodt Institute of Radiology, Washington University, Saint Louis MO, USA​

The benefit of dual utilization of exercise echocardiogram and myocardial perfusion in coronary ischemia management

Yzhar Charuzi, UCLA School of Medicine, Los Angeles CA, USA

Speckle tracking echocardiography – a 10 year perspective: What have we learned and where are we going?

Zvi Vered, Assaf Harofeh Medical Center and Tel Aviv University, Zerifin, Israel​

Clinical Aspects

Women and ischemic heart disease: an underappreciated (but important) condition

Giuseppe Ambrosio, University of Perugia School of Medicine, Italy

Stable ischemic heart disease: Treatment update 2015

Udho Thadani, University of Oklahoma, Oklahoma City OK, USA


Treatment of angina in the elderly

John D. Horowitz, University of Adelaide, Australia


Acute Coronary Syndromes

New sights into the pathophysiology of acute coronary syndromes derived from intravascular imaging

Robert L Wilensky, University of Pennsylvania, Philadelphia PA, USA

Pathogenesis of acute coronary syndromes

Filippo Crea, Catholic University of Rome, Rome, Italy

Universal definition of MI: update on the work of the task force

Joseph S. Alpert, University of Arizona Health Sciences Center, Tucson AZ, USA

Regional systems of care for STEMI: the US Perspective

Harold L. Dauerman, University of Vermont, Burlington VT, USA

In-hospital STEMI – predictors, treatment and outcomes

George A. Stouffer, University of North Carolina, Chapel Hill NC, USA


Primary PCI in Arabian Gulf countries

Abdullah Shehab, UAE University, United Arab Emirates​

Measures to prevent sudden cardiac death early after myocardial infarction

Antonis S. Manolis, Athens University School of Medicine, Greece​

Ischemic heart disease: myths and facts

Mario Marzilli, University of Pisa, Pisa, Italy​


Antiplatelet and Antithrombotic Therapy

Platelets and innate immunity in ACS

Ingo Ahrens, University Heart Centre Freiburg-Bad Krozingen, Germany

Ticagrelor, but not clopidogrel protects against reperfusion injury and improves adverse remodeling after myocardial infarction

Yochai Birnbaum, Baylor College of Medicine, Houston TX, USA

Long term dual antiplatelet therapy for secondary prevention after myocardial infarction

Yoseph Rozenman, Wolfson Medical Center and Tel Aviv University, Holon, Israel

Homogeneity and heterogeneity of the efficacy and safety of antiplatelet agents

Shinya Goto, Tokai University, Kanagawa, Japan

The GARFIELD Registry: A 2015 update

Matyas Keltai, Gottsegen Gyorgy Hungarian Institute of Cardiology, Budapest, Hungary


Pre and Post Conditioning - Saves the Heart?

Mechanisms of remote preconditioning
Gerd Heusch, Institute of Pathophysiology, Universitätsklinikum Essen, Essen,  Germany
 
Role of microRNAs and exosomes in cardioprotection
Peter Ferdinandy, Cardiovascular Research Group, University of Szeged, Department of Biochemistry, Szeged, Hungary 

Gene expression dynamics during preconditioning
Mariann Gyöngyösi, Department of Medicine II, Medical University of Vienna, Vienna, Austria 
 
Peripheral preconditioning – Clinical Overview 
Hans-Erik Bötger,  Department of Cardiology Aarhus University Hospital, Aarhus, Denmark  

Reduction in Infarct Size by Remote Per-postconditioning in Patients With ST-elevation Myocardial Infarction (RECOND)
John Pernow, Department of Medicine, Karolinska Universitetssjukhuset, Stockholm, Sweden ​

Mechanisms of cardioprotection of subcellular defects in ischemic reperfusion injury
Naranjan Dhalla, St. Boniface Hospital Research Centre, University of Manitoba, Winnipeg, Canada

Ventricular Function, Heart​ Failure

Intravenous vepoloxamer (purified poloxamer-188) for the treatment of heart failure

Hani Sabbah, Henry Ford Heart and Vascular Institute, Detroit MI, USA​


Interatrial shunt implantation for LA decompression and prevention of lung congestion  in patients with heart failure

Gad Keren, Tel Aviv Medical Center and Tel Aviv University, Tel Aviv, Israel

Aging and Heart Failure 2015: Role of Extracellular Matrix

Bodh Jugdutt, Canada

​​

Focus Session: Hypertension and the Heart

Hypertension and acute myocardial infarction

Marco De Carlo, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy

Hypertension and heart failure

Pietro Amedeo Modesti, University of Florence, Florence, Italy

Hypertension and atrial fibrillation

Luigi Padeletti, University of Florence, Florence, Italy

Hypertension and stable coronary artery disease

Roberto Pedrinelli , University of Pisa, Pisa, Italy​

​Interventional Cardiology

Andreas Gruent​​zig - forgotten innovator

Romeo J. Vecht, Wellington Hospital, London, UK


Culprit-only versus complete revascularization strategies to treat multivessel disease after primary PCI for STEMI

Giuseppe Di Pasquale, Ospedale Maggiore, Italy

Significance of incomplete revascularization in stable and unstable CAD

Sorin J. Brener, Weill Cornell Medical College, New York NY, USA

Unprotected left main disease PCI: SYNTAX mistakes

David Antoniucci, Careggi Hospital, Florence, Italy


PCI for chronic total occlusion: current status

Barry F. Uretsky, University of Arkansas for Medical Sciences, USA

Angiography alone is insufficient to guide PCI: The important role of direct coronary imaging

James A. Goldstein, William Beaumont Hospital, Royal Oak MI, USA​


CTO Revascularization: Is there a clinical benefit?

Ran Kornowski, Rabin Medical Centers and Tel Aviv University, Petah Tikva, Israel

Role of imaging (optical coherent tomography) during primary PCI for STEMI

Petr Kala, Brno, Czech Republic
​​​​

Decreasing radiation exposure during interventional cardiology procedures

Ariel Roguin, Rambam Medical Center and the Ruth and Bruce Rappaport School of Medicine, Haifa, Israel

Current status of robotic assisted PCI

George W. Vetrovec, VCUHS, Richmond VA, USA

The future management of coronary artery disease: Integrating anatomy, physiology and intervention

Giora Weisz, Shaarei Zedek Medical Center, Jerusalem, Israel

Very, very late drug-eluting stent thrombosis

Michael P. Savage, Thomas Jefferson University, Jefferson University Hospitals, Philadelphia PA , USA​

Valve Interventions, Structural Heart Disease

Catheter based valve therapy: where do we stand?

Roger J. Laham, Beth Israel Deaconess Medical Center, Boston MA, USA

Vascular access for transcatheter aortic valve implantation: challenges and novel solutions

Ronen Jaffe, Lady Davis Carmel Medical Center and the Ruth and Bruce Rappaport School of Medicine, Technion-IIT, Haifa, Israel

TAVI for intermediate and low risk patients. The time has come

Ariel Finkelstein, Tel Aviv Medical Center and Tel Aviv University, Tel Aviv, Israel

Valve-in-valve procedure for patients with degenerated bioprosthetic valve: Indications, technique, and results

Gerhard Schuler, Universitat Leipzig Herzzentrum, Leipzig, Germany​


The Valve Medical TAVI system - the only system with a real 12 FR profile

Kobi Richter, Medinol Systems, Jerusalem, Israel

Current limitations and future directions of transcatheter valvular interventions

Amit Segev, Sheba Medical Center and Tel Aviv University, Tel Hashomer, Israel​


TAVI - surgical and/or cardiological procedure?

Matthias Overbeck, German Hospital Tirana (Albania), Germany​

Carotid and Peripheral Interventions

Decision making in carotid artery disease

Bruce Gewertz, Cedars-Sinai Medical Center, Los Angeles CA, USA

Transcatheter left gastric artery therapy for treatment of obesity​

Nicholas N. Kipshidze, Lenox Hospital, New York NY, USA

Cardiac Surgery

Surgical options for end-stage coronary artery disease

Roland Hetzer, German Heart Institute, Berlin, Germany

Mechanical circulatory support in the era of organ shortage

Gino Gerosa, Policlinico Padova, Padua, Italy

Surgery for moderate ischemic mitral regurgitation- should we repair the valve?

Shuli Silberman, Shaarei Zedek Medical Center, Jerusalem, Israel​

Robotic experience with mitral valve repair

Alfredo Trento, Cedars-Sinai Medical Center, Los Angeles CA, USA​

Recent advances in the treatment of ischemic mitral regurgitation

Hermann Reichenspurner, Universitatsklinikum Eppendorf, Germany

Keep Me Updated